D-1076-2015 Class I Terminated
FDA drug recall D-1076-2015 was initiated by Hospira Inc. on Mar 6, 2015 and is designated Class I. Reason for recall: Labeling: Wrong Bar Code: There is a potential for some units to be mislabeled with an incorrect barcode on the immediate container that scans as heparin sodium 2000 USP units/1000 mL in 0.9% in… The recall status is terminated (terminated Oct 19, 2016). Affected quantity: 181,704 bags.
Recall Details
- Product Type
- Drugs
- Report Date
- May 20, 2015
- Initiation Date
- Mar 6, 2015
- Termination Date
- Oct 19, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 181,704 bags
Product Description
MAGNESIUM SULFATE IN 5% DEXTROSE INJECTION, USP, 10 mg/mL; 100 mL bag, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-6727-23, UPC (01) 0 030409 672723 1.
Reason for Recall
Labeling: Wrong Bar Code: There is a potential for some units to be mislabeled with an incorrect barcode on the immediate container that scans as heparin sodium 2000 USP units/1000 mL in 0.9% in sodium chloride injection.
Distribution Pattern
Nationwide
Code Information
Lot: 42-120-JT, Exp 01DEC2015
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1076-2015
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026